Provided by Tiger Trade Technology Pte. Ltd.

Roivant Sciences Ltd.

36.30
-0.5400-1.47%
Post-market: 36.360.0600+0.17%19:51 EDT
Volume:6.19M
Turnover:225.49M
Market Cap:26.22B
PE:-77.23
High:37.18
Open:37.03
Low:36.23
Close:36.84
52wk High:37.97
52wk Low:11.60
Shares:722.41M
Float Shares:581.00M
Volume Ratio:1.12
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4700
EPS(LYR):-0.5400
ROE:-8.52%
ROA:-16.48%
PB:6.20
PE(LYR):-67.22

Loading ...

Piper Sandler Sticks to Their Buy Rating for Roivant Sciences (ROIV)

TIPRANKS
·
Jun 16

Immunovant director Andrew J. Fromkin reports common share disposal worth $7.44 million

Reuters
·
May 30

Roivant Sciences Is Maintained at Buy by Guggenheim

Dow Jones
·
May 26

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Crescent Biopharma (CBIO) and Genmab (GMAB)

TIPRANKS
·
May 26

Roivant Sciences price target raised to $31.50 from $29.50 at BofA

TIPRANKS
·
May 25

Roivant President, Immunovant CEO Eric Venker disposes common shares worth $7.23 million

Reuters
·
May 23

Should Roivant’s One‑Off Driven Profitability Shift Require Action From Roivant Sciences (ROIV) Investors?

Simply Wall St.
·
May 22

Roivant Sciences Price Target Maintained With a $34.00/Share by HC Wainwright & Co.

Dow Jones
·
May 21

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Kindly MD (NAKA) and Roivant Sciences (ROIV)

TIPRANKS
·
May 21

Roivant Sciences Ltd : Leerink Partners Raises Target Price to $42 From $38

THOMSON REUTERS
·
May 21

Immunovant director Atul Pande disposes 6,000 shares for $192,000

Reuters
·
May 21

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Hasbro, Micron

Reuters
·
May 21

Stock Track | Roivant Sciences Soars 15.99% Intraday on Unexpected Q4 Profit and Promising Arthritis Drug Data

Stock Track
·
May 21

Roivant Sciences rises 15.2%

TIPRANKS
·
May 21

BUZZ-U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, AMC Entertainment, Roivant

Reuters
·
May 20

2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug -- Barrons.com

Dow Jones
·
May 20

BUZZ-Roivant rises as arthritis drug shows early promise

Reuters
·
May 20

Movement Alert|Roivant Sciences Rises 11.1% in Regular Trading, Business Progress Updates Drive Positive Market Reaction Despite Revenue Miss

Market Focus
·
May 20

Roivant Sciences Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 20

Immunovant Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 20